nirsevimab — التعريف

Nirsevimab is a drug in human monoclonal anti body structure, developed against respiratory synsityal virus (RSV). In order to prevent RSV infections, it is mainly used in sensitive groups such as early infant and high risk pediatric patients. The drug acts by blocking the introduction of RSV to cells and is applied as a single dose throughout the season. والنيرسفيمب فعال في الحد من شدة الإصابات الجهاز التنفسي الأدنى المرتبطة بمعدلات التلفزيون والضيافة.